These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 12049620

  • 21. Urocortin 2 sustains haemodynamic and renal function during introduction of beta-blockade in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls G, Richards M.
    J Hypertens; 2011 Sep; 29(9):1787-95. PubMed ID: 21720262
    [Abstract] [Full Text] [Related]

  • 22. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K, Bleifeld W.
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [Abstract] [Full Text] [Related]

  • 23. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
    Nekooeian AA, Ogilvie RI, Zborowska-Sluis D.
    Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
    [Abstract] [Full Text] [Related]

  • 24. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G, Lauri G, Assanelli E, Grazi M, Guazzi M, Berna G, Salvioni A, Agostoni P.
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [Abstract] [Full Text] [Related]

  • 25. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II.
    Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T.
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):116-25. PubMed ID: 9456286
    [Abstract] [Full Text] [Related]

  • 26. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y, Tharaux PL, Ragueneau I, Dussaule JC, Picker JL, Funck-Brentano C, Jaillon P.
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [Abstract] [Full Text] [Related]

  • 27. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y, Hasegawa K, Sawayama T, Inoue S, Nakamura T, Kakumae S, Tadaoka S, Nakao M, Nezuo S.
    Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
    [Abstract] [Full Text] [Related]

  • 28. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM, Kriegel AJ, Greene AS.
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
    [Abstract] [Full Text] [Related]

  • 29. Acute renal effects of captopril in patients with congestive heart failure.
    Ribstein J, Mimran A.
    J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
    [Abstract] [Full Text] [Related]

  • 30. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [Abstract] [Full Text] [Related]

  • 31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 32. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M, Eugène M, Evans J, Laurenceau JL, Hubermann JP, Thomas D, Drobinski G, Leprince JL, Ganty J, Wajman A, Guedj D, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [Abstract] [Full Text] [Related]

  • 33. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK.
    N Engl J Med; 1980 Jun 19; 302(25):1373-9. PubMed ID: 6246425
    [Abstract] [Full Text] [Related]

  • 34. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT, Cameron VA, Charles CJ, Richards AM.
    Circulation; 2005 Dec 06; 112(23):3624-32. PubMed ID: 16330704
    [Abstract] [Full Text] [Related]

  • 35. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure].
    Riegger AJ.
    Klin Wochenschr; 1991 Dec 06; 69 Suppl 24():20-3. PubMed ID: 1830909
    [Abstract] [Full Text] [Related]

  • 36. Captopril and angiotensin II receptor antagonist therapy in a pacing model of heart failure.
    Ogilvie RI, Zborowska-Sluis D.
    Can J Cardiol; 1998 Aug 06; 14(8):1025-33. PubMed ID: 9738162
    [Abstract] [Full Text] [Related]

  • 37. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 06; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 38. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG, Giraud P, Puel J, Cassagneau B, Sabot G, Fauvel JM, Bounhoure JP.
    Nouv Presse Med; 1981 Apr 30; 10(19):1583-6. PubMed ID: 6269558
    [Abstract] [Full Text] [Related]

  • 39. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S.
    Curr Med Res Opin; 2001 Apr 30; 17(4):290-7. PubMed ID: 11922403
    [Abstract] [Full Text] [Related]

  • 40. Long-term adrenomedullin administration in experimental heart failure.
    Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM.
    Hypertension; 2002 Nov 30; 40(5):667-72. PubMed ID: 12411460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.